These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3295097)

  • 1. [Update on the treatment of systemic scleroderma].
    Priollet P; Cazalis P; Valleteau de Moulliac M
    J Mal Vasc; 1987; 12(2):213-7. PubMed ID: 3295097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of systemic scleroderma using plasma exchange. A study of 19 cases].
    Schmidt C; Schooneman F; Siebert P; Weber M; Dureux JB; Streiff F; Schmitt J
    Ann Med Interne (Paris); 1988; 139 Suppl 1():20-2. PubMed ID: 3247984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Penicillamine therapy in systemic sclerosis.
    Jayson MI; Lovell C; Black CM; Wilson RS
    Proc R Soc Med; 1977; 70 Suppl 3(Suppl 3):82-8. PubMed ID: 122683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation factor XIII, endothelial damage and systemic sclerosis.
    Marzano AV; Federici AB; Gasparini G; Mannucci PM; Caputo R; Berti E
    Eur J Dermatol; 2000; 10(1):14-7. PubMed ID: 10694291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of generalized systemic sclerosis.
    Torres MA; Furst DE
    Rheum Dis Clin North Am; 1990 Feb; 16(1):217-41. PubMed ID: 2406809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of progressive systemic sclerosis using factor XIII.
    Guillevin L; Chouvet B; Mery C; De Gery A; Thivolet J; Godeau P; Delbarre F
    Pharmatherapeutica; 1985; 4(2):76-80. PubMed ID: 3903781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatments of progressive systemic sclerosis].
    Vayssairat M; Abdoucheli-Baudot N; Gaitz JP
    J Mal Vasc; 2001 Oct; 26(4):258-61. PubMed ID: 11679856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
    Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
    Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal scleroderma crisis. Role of scleroderma vasculopathy in the induction of cutaneous and visceral fibrosis in 2 cases].
    Cuchacovich M; Holuigue G; Gatica H; Alvo M; Murray G
    Rev Med Chil; 2000 Jan; 128(1):86-92. PubMed ID: 10883527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognosis and treatment of scleroderma].
    Crickx B; Belaich S
    Ann Med Interne (Paris); 1984; 135(8):624-9. PubMed ID: 6529058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis/scleroderma: a treatable multisystem disease.
    Hinchcliff M; Varga J
    Am Fam Physician; 2008 Oct; 78(8):961-8. PubMed ID: 18953973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for the cutaneous manifestations of systemic sclerosis.
    Dutz J
    Skin Therapy Lett; 2000; 6(1):3-5. PubMed ID: 11027421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis.
    Knobler RM; French LE; Kim Y; Bisaccia E; Graninger W; Nahavandi H; Strobl FJ; Keystone E; Mehlmauer M; Rook AH; Braverman I;
    J Am Acad Dermatol; 2006 May; 54(5):793-9. PubMed ID: 16635659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic targets in systemic sclerosis.
    Denton CP
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S6. PubMed ID: 17767744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of systemic scleroderma].
    Priollet P; Baudot N; Fiessinger JN; Vayssairat M; Housset E
    Ann Dermatol Venereol; 1984; 111(6-7):595-607. PubMed ID: 6388467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.